Viral infections trigger exacerbations of cystic fibrosis in adults and children.

Acknowledgements: The authors are grateful for the willingness of the patients and experts who were involved in the process. Their contribution has been highly valued. Also the collaboration with the Asthma Foundation lung patients association, Dutch Sarcoidosis interest group, Dutch PHA Foundation, Dutch Cystic Fibrosis Foundation and the Dutch Pulmonary Fibrosis organisation was of great value to us. REFERENCES 1 Caron-Flinterman JF, Broerse JEW, Bunders JFG. Patient partnership in decision-making on biomedical research: changing the network. Sci Technol Hum Val 2007; 32: 339–368. 2 Entwistle VA, Renfrew MJ, Yearley S, et al. Lay perspectives: advantages for health research. BMJ 1998; 316: 463–466. 3 Tallon D, Chard J, Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000; 355: 2037–2040. 4 Telford R, Beverley CA, Cooper CL, et al. Consumer involvement in health research: fact or fiction? Br J Clinical Gov 2002; 7: 92–103. 5 Lloyd K, White J. Democratizing clinical research. Nature 2011; 474: 277–278. 6 Stewart RJ, Caird J, Oliver K, et al. Patients’ and clinicians’ research priorities. Health Expect 2011; 14: 439–448. 7 Caron-Flinterman JF, Broerse JE, Teerling J, et al. Patients’ priorities concerning health research: the case of asthma and COPD research in the Netherlands. Health Expect 2005; 8: 253–263. 8 Caron-Flinterman JF, Broerse JEW, Teerling J, et al. Stakeholder participation in health research agenda setting: the case of asthma and COPD research in the Netherlands. Sci Public Policy 2006; 33: 291–304. 9 Abma TA, Broerse JEW. Patient participation as dialogue: setting research agendas. Health Expect 2010; 13: 160–173. 10 Cornwall A, Jewkes R. What is participatory research? Soc Sci Med 1995; 41: 1667–1676.